KCNA10, also known as potassium voltage-gated channel subfamily A member 10, is an integral membrane protein and part of the voltage-gated potassium channel group. These channels are pivotal for maintaining the resting membrane potential and repolarization phase of action potentials in excitable cells. The function of the KCNA10 protein spans the fine-tuning of electrical signaling in both neuronal and muscle tissues, contributing to the precise control of their excitability. The expression of KCNA10 is a highly regulated process within the cell, subject to a dynamic interplay of transcriptional control. The genetic promotor regions of KCNA10 can be responsive to various intracellular signaling molecules, allowing the cell to adapt to changes in physiological conditions by altering the abundance of this potassium channel.
A collection of chemical compounds has been identified that can potentially serve as activators for the expression of the KCNA10 protein. These activators operate through diverse mechanisms, stimulating intracellular pathways that converge on the transcriptional machinery governing KCNA10 expression. For instance, retinoic acid, a metabolite of vitamin A, may enhance transcription by binding to nuclear receptors that then interact with DNA at specific response elements. Similarly, vitamin D3, through its active form, can engage with nuclear receptors that dimerize with partner molecules to stimulate gene expression. Other compounds like forskolin elevate intracellular cAMP levels, thereby activating protein kinase A, which can phosphorylate and activate transcription factors that target the KCNA10 promoter. Epigenetic modifiers, such as the DNA methyltransferase inhibitor 5-Aza-2'-deoxycytidine, can induce gene expression by demethylating DNA and making the promoter regions more accessible to transcription factors. Meanwhile, histone deacetylase inhibitors like trichostatin A can promote a more open chromatin state, facilitating the transcription of various genes, including those encoding ion channels. These activators underscore the complexity of cellular regulation and highlight the intricate web of signals that can influence the expression of essential proteins like KCNA10.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid binds to its nuclear receptors, which then bind to retinoic acid response elements (RARE) in the promoter regions of target genes, potentially upregulating the transcription of genes such as KCNA10. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $70.00 $160.00 $290.00 | 2 | |
Cholecalciferol, through its hormonally active form calcitriol, engages with vitamin D receptors (VDRs) that heterodimerize with retinoid X receptors (RXRs) and stimulate the transcription of voltage-gated potassium channels. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, catalyzing the conversion of ATP to cAMP, which activates protein kinase A (PKA). PKA phosphorylates transcription factors that can upregulate KCNA10 expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
By inhibiting DNA methyltransferase, 5-Aza-2′-Deoxycytidine causes hypomethylation of gene promoters, which can lead to the reactivation of epigenetically silenced genes, including potentially KCNA10. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A inhibits histone deacetylase, allowing for a more relaxed chromatin structure and increased access for transcription factors to DNA, possibly resulting in the enhanced transcription of KCNA10. | ||||||
Hydrocortisone | 50-23-7 | sc-300810 | 5 g | $100.00 | 6 | |
Hydrocortisone binds to glucocorticoid receptors, which may translocate to the nucleus and bind glucocorticoid response elements (GREs) in the promoter region of genes, leading to the stimulation of genes including potassium channels. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium inhibits GSK-3, which is a negative regulator of the Wnt signaling pathway; this inhibition can lead to increased transcription of Wnt target genes, and potentially, the upregulation of KCNA10. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
Epigallocatechin gallate has been shown to exert epigenetic changes by remodeling chromatin, which could lead to the activation of certain genes, including possible upregulation of the KCNA10 gene. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
As a histone deacetylase inhibitor, sodium butyrate can cause an open chromatin state, enhancing the transcriptional activity of several genes, which may include an increase in KCNA10 expression. | ||||||
L-3,3′,5-Triiodothyronine, free acid | 6893-02-3 | sc-204035 sc-204035A sc-204035B | 10 mg 100 mg 250 mg | $40.00 $75.00 $150.00 | ||
T3 hormone binds to thyroid hormone receptors, which then bind to thyroid hormone response elements (TREs) on DNA, possibly stimulating the transcription of genes involved in ion transport such as KCNA10. | ||||||